nefiracetam has been researched along with Seizures in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Duan, CZ; Fu, CY; He, XY; Huang, ZW; Li, J; Li, XF; Zhang, X | 1 |
| Hashizume, K; Hodozuka, A; Nakai, H; Sawamura, A; Tanaka, T; Tsuda, H; Yoshida, K | 1 |
| Kitano, Y; Komiyama, C; Makino, M; Sakurada, S; Takasuna, K; Takazawa, A | 1 |
| Aoki, T; Kinoshita, M; Kitano, Y; Komiyama, C; Makino, M; Sakurada, S; Satoh, H; Takasuna, K; Takazawa, A; Yamauchi, T | 1 |
| Kasai, Y; Kinoshita, M; Kitano, Y; Komiyama, C; Makino, M; Sakurada, S; Takasuna, K; Takazawa, A; Yamauchi, T; Yamazaki, O | 1 |
| Nabeshima, T; Nakamoto, Y; Shiotani, T; Watabe, S; Yoshii, M | 1 |
| Hashizume, K; Kunimoto, M; Maeda, T; Tanaka, T | 1 |
1 review(s) available for nefiracetam and Seizures
| Article | Year |
|---|---|
Basic science and epilepsy: experimental epilepsy surgery.
Topics: Amygdala; Animals; Anticonvulsants; Cats; Combined Modality Therapy; Corpus Callosum; Drug Evaluation; Electroencephalography; Epilepsy; Epilepsy, Temporal Lobe; Hippocampus; Kainic Acid; Models, Animal; Neurosurgical Procedures; Nootropic Agents; Pyrrolidinones; Rats; Seizures; Stereotaxic Techniques | 2001 |
6 other study(ies) available for nefiracetam and Seizures
| Article | Year |
|---|---|
Nefiracetam Attenuates Pro-Inflammatory Cytokines and GABA Transporter in Specific Brain Regions of Rats with Post-Ischemic Seizures.
Topics: Amygdala; Animals; Brain; Brain Ischemia; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; GABA Plasma Membrane Transport Proteins; Hippocampus; Male; Parietal Lobe; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Seizures | 2015 |
Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Levetiracetam; Male; Mice; Nootropic Agents; Pentylenetetrazole; Piracetam; Pyrrolidinones; Rats; Rats, Wistar; Seizures | 2005 |
Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Interactions; Kainic Acid; Male; Neuroprotective Agents; Pyrrolidinones; Rats; Rats, Wistar; Seizures; Statistics as Topic; Time Factors | 2005 |
Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
Topics: Administration, Oral; Amygdala; Animals; Anticonvulsants; Behavior, Animal; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Epilepsy, Complex Partial; Humans; Kindling, Neurologic; Levetiracetam; Male; Nootropic Agents; Piracetam; Pyrrolidinones; Rats; Rats, Wistar; Seizures | 2005 |
Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors.
Topics: Animals; Anticonvulsants; Benzodiazepinones; Convulsants; Disease Models, Animal; Epilepsy; Male; Mice; Mice, Inbred Strains; Nootropic Agents; Pyrrolidinones; Radioligand Assay; Receptors, GABA-A; Seizures | 2000 |
Antiepileptic effect of nefiracetam on kainic acid-induced limbic seizure in rats.
Topics: Animals; Anticonvulsants; Brain Chemistry; Electrophysiology; Electroshock; Excitatory Amino Acid Agonists; Glucose; Kainic Acid; Limbic System; Male; Pyrrolidinones; Rats; Rats, Wistar; Seizures | 2000 |